ALIMERA SCIENCES, INC. Net Change in Cash
ALIMERA SCIENCES, INC. reported Net Change in Cash of -$1.23 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-08-07
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $2.26M, a 71.13% decline year-over-year.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $7.81M.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$6.57M.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$2.94M, a 204.51% decline year-over-year.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $6.79M.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$11.24M, a 312.00% decline from fiscal 2021.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $5.30M, a 197.36% increase from fiscal 2020.
- ALIMERA SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $1.78M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$1.23M 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $2.26M 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $6.79M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | $3.01M 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $13.50M 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $7.81M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$11.24M 10-K · filed 2024-03-08 | |||
| 2022-09-30 | -$11.00M 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | -$8.65M 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$6.57M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $5.30M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $10.32M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $13.57M 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | -$2.94M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $1.78M 10-K · filed 2022-03-23 | |||
| 2020-09-30 | $1.83M 10-Q · filed 2021-11-05 | |||
| 2020-06-30 | $4.07M 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $2.81M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$3.62M 10-K · filed 2021-03-05 | |||
| 2019-09-30 | -$5.14M 10-Q · filed 2020-11-03 | |||
| 2019-06-30 | -$886.00K 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | $52.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$11.03M 10-K · filed 2020-03-02 | |||
| 2018-09-30 | -$11.48M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | -$7.38M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$3.81M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$6.91M 10-K · filed 2019-02-25 | |||
| 2017-09-30 | -$5.35M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$4.09M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$4.24M 10-Q · filed 2018-05-09 |